Norofert S.A.

BVB:NRF Stock Report

Market Cap: RON 46.4m

Norofert Past Earnings Performance

Past criteria checks 0/6

Norofert's earnings have been declining at an average annual rate of -18.5%, while the Chemicals industry saw earnings growing at 0.5% annually. Revenues have been declining at an average rate of 3.6% per year.

Key information

-18.47%

Earnings growth rate

-42.14%

EPS growth rate

Chemicals Industry Growth39.70%
Revenue growth rate-3.61%
Return on equity-3.00%
Net Margin-3.20%
Next Earnings Update29 Sep 2026

Recent past performance updates

Recent updates

Analysis Article Jan 17

Norofert S.A.'s (BVB:NRF) Business Is Trailing The Industry But Its Shares Aren't

With a median price-to-sales (or "P/S") ratio of close to 1.4x in the Chemicals industry in Romania, you could be...
Analysis Article Dec 03

Some Investors May Be Worried About Norofert's (BVB:NRF) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Analysis Article Jul 15

Here's Why Norofert (BVB:NRF) Has A Meaningful Debt Burden

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article May 24

Optimistic Investors Push Norofert S.A. (BVB:NRF) Shares Up 28% But Growth Is Lacking

Norofert S.A. ( BVB:NRF ) shareholders have had their patience rewarded with a 28% share price jump in the last month...
Analysis Article May 17

There Are Reasons To Feel Uneasy About Norofert's (BVB:NRF) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Analysis Article Apr 01

Norofert S.A.'s (BVB:NRF) Price In Tune With Revenues

It's not a stretch to say that Norofert S.A.'s ( BVB:NRF ) price-to-sales (or "P/S") ratio of 1.2x seems quite...
Analysis Article Sep 19

Is Norofert (BVB:NRF) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Revenue & Expenses Breakdown

How Norofert makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BVB:NRF Revenue, expenses and earnings (RON Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2635-170
31 Dec 2541470
30 Sep 2539680
30 Jun 2543570
31 Mar 2548970
31 Dec 2445370
30 Sep 2444-470
30 Jun 2443-570
31 Mar 2442-670
31 Dec 2344-470
30 Sep 2353440
30 Jun 2365850
31 Mar 23711050
31 Dec 22731150
30 Sep 22761060
30 Jun 2264850
31 Mar 22641050
31 Dec 2153750
30 Sep 2138340
30 Jun 2131540
31 Mar 2123140
31 Dec 2025440
30 Sep 2030940
30 Jun 2027840
31 Mar 2021630
31 Dec 1915520
31 Dec 1810410

Quality Earnings: NRF is currently unprofitable.

Growing Profit Margin: NRF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NRF is unprofitable, and losses have increased over the past 5 years at a rate of 18.5% per year.

Accelerating Growth: Unable to compare NRF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NRF is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (1.2%).


Return on Equity

High ROE: NRF has a negative Return on Equity (-3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/09 16:38
End of Day Share Price 2026/07/09 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Norofert S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.